TH
Aspen Pharmacare HLDGS (JSE: APN)
Last traded- Open
- R156.23
- Prev Close
- R158.71
- Day High
- R159.15
- Day Low
- R156.23
Key statistics
| Market cap | R68.5B |
|---|---|
| P/E | N/A |
| EPS | N/A |
| Div yield | 1.47% |
| 52W high | R166.21 |
| 52W low | R90.70 |
| Volume | 903K |
| Listed | N/A |
Price and fundamentals data is supplied by EODHD, with Yahoo Finance as a fallback source. Sentiment is computed by StockTalk SA from 32 live member stances recorded by registered members on this page.
What the community is sayingBearish
Aspen Pharmacare is trading at 158.08 and down today, with investors showing mixed sentiment between concern and patience. Supporters are holding steady as the stock maintains support above 157, while others question whether to continue holding.
Summarized from 3 posts · updated nightly
Filter:Ask about APN
NI
DA
SI
NO
MO
FR
NI
BO
MP
NO
MO
Mogale K.@mogale_morning·MemberBearish
APN at R156.50 is still fighting to hold above that 150 level, but the pharma headwinds aren't going away anytime soon. Revenue growth has been patchy and margins are under pressure, so I'm not convinced this bounce has legs until we see some actual earnings traction.
MO
MomentumTracker@momentumtracker_jse·Neutral
APN's been treading water around the R156 mark, caught between solid pharma fundamentals and currency headwinds that keep biting into rand-converted earnings. The dividend yield is decent enough to justify holding, but you need patience here: growth is steady rather than explosiv
PE
Pete van W.@pedant_pete·MemberBullish
Picked up some APN at R159.52 after that 3.26% pop, reckoning the healthcare defensive play offers decent value with the dividend yield holding up despite recent volatility.
MO
MomentumTracker@momentumtracker_jse·Bullish
Grabbed some APN at R154 on that 3.74% pop today, thinking the healthcare defensive play still offers value even if the dividend yield has compressed a bit.
SC
Scandi64@scandi_jse64·MemberNeutral
APN up 1.39% today, quietly building momentum. Stock's been range-bound for a while but if they can deliver on earnings growth, that 2.8% yield starts looking decent at these levels.
NI
Nico van D.@nico_the_analyst·Neutral
APN catching a bid today at R149.13 but the P/E still looks stretched relative to earnings growth. Revenue flatness in emerging markets is the real concern here, not just the rand headwinds.
GU
GUPPY@guppy_jse·MemberNeutral
APN's up 2.70% today but the real story is whether management can execute on cost-cutting while defending market share in a tough pharma landscape. Long-term, the dividend yield keeps me interested if they can stabilise earnings and get that debt situation under control, but exec
TS
tsquared@tsquared_jse·MemberNeutral
APN's down a touch today but the dividend yield is still sitting pretty around 4.5%, which keeps it on the radar for income hunters. P/E looks reasonable for pharma, though you've got to keep an eye on forex headwinds hitting those international revenues.
TR